General Information of DTT (ID: TT4J8MF)

DTT Name Thyrotropin-releasing hormone receptor (TRHR) DTT Info
Gene Name TRHR

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Discontinued Drug(s)
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
protirelin DMGN5QD Central nervous system disease 8A04-8D87 Approved [1]
------------------------------------------------------------------------------------
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
AZETIRELIN DMLY9F1 Pain MG30-MG3Z Phase 3 [2]
------------------------------------------------------------------------------------
3 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
MONTIRELIN TETRAHYDRATE DM31OGZ Pain MG30-MG3Z Discontinued in Preregistration [3]
Posatirelin DML6EWH Neurodegenerative disorder 8A20-8A23 Discontinued in Phase 3 [4]
JTP-2942 DM29C6S Cognitive impairment 6D71 Discontinued in Phase 2 [5]
------------------------------------------------------------------------------------
4 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
C4X-101 DM5971G Endocrine disease 5B3Z Investigative [6]
CORYMBONE B DM463S2 Discovery agent N.A. Investigative [7]
MeTRH DMGH8WV Discovery agent N.A. Investigative [8]
MK-771 DM4YQV0 Discovery agent N.A. Investigative [9]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Company report (takeda)
2 Intestinal absorption of azetirelin, a new thyrotropin-releasing hormone (TRH) analogue. II. In situ and in vitro absorption characteristics of azetirelin from the rat intestine. Biol Pharm Bull. 1995 Jul;18(7):976-9.
3 Montirelin hydrate (NS-3), a TRH analog, improved the disturbance of consciousness caused by head concussion and pentobarbital in mice. Nihon Yakurigaku Zasshi. 1996 May;107(5):237-45.
4 TRH analogs at Gedeon Richter Ltd.: highlights of experimental and clinical efficacy of posatirelin. Acta Pharm Hung. 2002;72(1):62-8.
5 Effect of JTP-2942, a novel thyrotropin-releasing hormone analogue, on pentobarbital-induced anesthesia in rats. Eur J Pharmacol. 1995 Mar 24;276(1-2):177-82.
6 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 363).
7 Corymbones A and B, phloroglucinols with thyrotropin releasing hormone receptor 2 binding affinity from the flowers of Corymbia peltata. J Nat Prod. 2008 May;71(5):881-3.
8 Thyrotropin-releasing hormone receptor type 1 (TRH-R1), not TRH-R2, primarily mediates taltirelin actions in the CNS of mice. Neuropsychopharmacology. 2013 May;38(6):950-6.
9 TRH analog MK-771 reverses neurochemical and learning deficits in medial septal-lesioned rats. Peptides. 1989 Jan-Feb;10(1):121-4.